Fibrinogen consumption and use of heparin are risk factors for delayed bleeding during acute promyelocytic leukemia induction.

WF Novotny, M Palmier, TC Wun, GJ Jr Broze, JP Miletich, Purification and properties of heparin-releasable lipoprotein-associated coagulation inhibitor. Blood. ,vol. 78, pp. 394- 400 ,(1991) , 10.1182/BLOOD.V78.2.394.394

HM Golomb, J Vardiman, JD Rowley, Acute nonlymphocytic leukemia in adults: correlations with Q-banded chromosomes. Blood. ,vol. 48, pp. 9- 21 ,(1976) , 10.1182/BLOOD.V48.1.9.9

Jae H. Park, Baozhen Qiao, Katherine S. Panageas, Maria J. Schymura, Joseph G. Jurcic, Todd L. Rosenblat, Jessica K. Altman, Dan Douer, Jacob M. Rowe, Martin S. Tallman, Early death rate in acute promyelocytic leukemia remains high despite all-trans retinoic acid Blood. ,vol. 118, pp. 1248- 1254 ,(2011) , 10.1182/BLOOD-2011-04-346437

Dae-Young Kim, Je-Hwan Lee, Jung-Hee Lee, Sung-Doo Kim, Sung-Nam Lim, Yunsuk Choi, Young-Shin Lee, Young-Ah Kang, Miee Seol, Mijin Jeon, Joo Youn Kim, Kyung-Hwa Lee, Yeon-Joo Lee, Kyoo-Hyung Lee, Significance of fibrinogen, D-dimer, and LDH levels in predicting the risk of bleeding in patients with acute promyelocytic leukemia Leukemia Research. ,vol. 35, pp. 152- 158 ,(2011) , 10.1016/J.LEUKRES.2010.05.022

T. Wassenaar, J. Black, B. Kahl, B. Schwartz, W. Longo, D. Mosher, E. Williams, Acute promyelocytic leukaemia and acquired α-2-plasmin inhibitor deficiency: a retrospective look at the use of epsilon-aminocaproic acid (Amicar) in 30 patients Hematological Oncology. ,vol. 26, pp. 241- 246 ,(2008) , 10.1002/HON.867

BRADFORD S SCHWARTZ, ELIOT C WILLIAMS, MAUREEN G CONLAN, DEANE F MOSHER, Epsilon-Aminocaproic Acid in the Treatment of Patients with Acute Promyelocytic Leukemia and Acquired Alpha-2-Plasmin Inhibitor Deficiency Annals of Internal Medicine. ,vol. 105, pp. 873- 877 ,(1986) , 10.7326/0003-4819-105-6-873

Jill S. Menell, Gabriela M. Cesarman, Andrew T. Jacovina, Mary Ann McLaughlin, Emil A. Lev, Katherine A. Hajjar, Annexin II and Bleeding in Acute Promyelocytic Leukemia The New England Journal of Medicine. ,vol. 340, pp. 994- 1004 ,(1999) , 10.1056/NEJM199904013401303

Aditi Choudhry, Thomas G. DeLoughery, Bleeding and thrombosis in acute promyelocytic leukemia American Journal of Hematology. ,vol. 87, pp. 596- 603 ,(2012) , 10.1002/AJH.23158

Giuseppe Avvisati, HarryR. Büller, JanWouterTen Cate, Franco Mandelli, Tranexamic acid for control of haemorrhage in acute promyelocytic leukaemia. The Lancet. ,vol. 334, pp. 122- 124 ,(1989) , 10.1016/S0140-6736(89)90181-5

Steven D. Gore, Ivana Gojo, Mikkael A. Sekeres, Lawrence Morris, Marcel Devetten, Katarzyna Jamieson, Robert L. Redner, Robert Arceci, Ibitayo Owoeye, Tianna Dauses, Esther Schachter-Tokarz, Robert E. Gallagher, Single Cycle of Arsenic Trioxide-Based Consolidation Chemotherapy Spares Anthracycline Exposure in the Primary Management of Acute Promyelocytic Leukemia Journal of Clinical Oncology. ,vol. 28, pp. 1047- 1053 ,(2010) , 10.1200/JCO.2009.25.5158